The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined ...

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno ...

In recent years, the scale of biopharma investment into Ireland has accelerated, with some significant investments being made by the biggest companies in the industry. The country has always been ...

Europe to review safety data for Eisai-Biogen Alzheimer's drug Healthcare & Pharmaceuticalscategory· January 31, 2025 Indian biopharma company Biocon reported third-quarter revenue on Thursday ...

After hours: February 13 at 4:39:57 PM EST Loading Chart for ZBIO ...

Kubernetes Operator for Argo Rollouts controller.

Researching and developing therapeutic products for human use.